AVADEL PHARMACEUTICALS PLC - AVDL
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Two Seas Capital LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Two Seas Capital GP LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Sina Toussi | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 1.9% | 1,823,865 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | BRANDES INVESTMENT PARTNERS, LP | 0.2% | 218,835 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Tontine Asset Associates, LLC | 2.9% | 2,859,475 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Tontine Capital Overseas Master Fund II, L.P. | 2.9% | 2,859,475 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Jeffrey L. Gendell | 4.9% | 4,839,357 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 7.7% | 7,429,718 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.